Given the limitations and adverse effects observed in traditional periodontitis treatment, such as bacterial resistance to antimicrobial agents (51), it is essential to study natural compounds that can hinder the development of periodontopathogenic bacteria, alter the host inflammatory response, suppress local periodontal inflammation, and specifically lessen NF-κB activation. The gene discussed is NFKB1; the disease is periodontitis.